EP2661625A4 - Diagnoseverfahren - Google Patents

Diagnoseverfahren

Info

Publication number
EP2661625A4
EP2661625A4 EP12732021.6A EP12732021A EP2661625A4 EP 2661625 A4 EP2661625 A4 EP 2661625A4 EP 12732021 A EP12732021 A EP 12732021A EP 2661625 A4 EP2661625 A4 EP 2661625A4
Authority
EP
European Patent Office
Prior art keywords
diagnostic methods
diagnostic
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12732021.6A
Other languages
English (en)
French (fr)
Other versions
EP2661625A1 (de
Inventor
Mark Kopnitsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeus Scientific Inc
Original Assignee
Zeus Scientific Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeus Scientific Inc filed Critical Zeus Scientific Inc
Publication of EP2661625A1 publication Critical patent/EP2661625A1/de
Publication of EP2661625A4 publication Critical patent/EP2661625A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Physiology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP12732021.6A 2011-01-05 2012-01-04 Diagnoseverfahren Withdrawn EP2661625A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161429892P 2011-01-05 2011-01-05
US201161524630P 2011-08-17 2011-08-17
PCT/US2012/020234 WO2012094427A1 (en) 2011-01-05 2012-01-04 Diagnostic methods

Publications (2)

Publication Number Publication Date
EP2661625A1 EP2661625A1 (de) 2013-11-13
EP2661625A4 true EP2661625A4 (de) 2014-10-29

Family

ID=46457702

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12732021.6A Withdrawn EP2661625A4 (de) 2011-01-05 2012-01-04 Diagnoseverfahren

Country Status (6)

Country Link
EP (1) EP2661625A4 (de)
JP (1) JP2014501932A (de)
CN (1) CN103460043A (de)
AU (1) AU2012204413A1 (de)
CA (1) CA2860690A1 (de)
WO (1) WO2012094427A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3591406A1 (de) 2018-07-06 2020-01-08 Euroimmun Medizinische Labordiagnostika AG Vorrichtung und verfahren zur antikörperdetektion
EP3591401A1 (de) 2018-07-06 2020-01-08 Euroimmun Medizinische Labordiagnostika AG Verfahren zum automatisierten detektieren von antikörpern in einer flüssigen biologischen probe unter verwendung eines antigen-chips und antigen-chip hierfür

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60183559A (ja) * 1984-02-29 1985-09-19 Otsuka Pharmaceut Co Ltd 肝細胞膜抗原に対する自己抗体の測定方法
US5518881A (en) * 1993-11-02 1996-05-21 Flinders Medical Centre Transfected cell lines expressing autoantigens and their use in immunoassays for the detection of autoimmune disease
WO2003016575A1 (en) * 2001-08-17 2003-02-27 Luminex Corporation Method for characterizing autoimmune disorders
WO2003048300A2 (en) * 2001-11-30 2003-06-12 Amnis Corporation Methods of identifying cellular target molecules
WO2010030624A1 (en) * 2008-09-09 2010-03-18 Zeus Scientific, Inc. Methods for diagnosis and assessment of autoimmune disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE496288T1 (de) * 1995-10-11 2011-02-15 Luminex Corp Gleichzeitige mehrfachanalyse klinischer proben
CN1101936C (zh) * 2000-08-14 2003-02-19 李永哲 一种抗核抗体检测试剂及其制备方法
CN2653510Y (zh) * 2003-09-25 2004-11-03 长沙福滋堂生物技术开发有限公司 抗核抗体检测细胞薄片
JP2010510528A (ja) * 2006-11-22 2010-04-02 ライフ テクノロジーズ コーポレーション 自己免疫疾患のバイオマーカー
CN101017168B (zh) * 2007-02-15 2012-08-29 广州万孚生物技术股份有限公司 荧光胶乳定量层析试纸条及其制备方法
DE102007052281A1 (de) * 2007-11-02 2009-05-07 Zenteris Gmbh Einschritt-Multiplex-Immuntest
AU2008323375A1 (en) * 2007-11-13 2009-05-22 Medipan Gmbh Method for end-titre determination and the evaluation thereof by means of an indirect immunofluorescence assay
US8630690B2 (en) * 2009-05-05 2014-01-14 Electric Power Research Institute, Inc. Thermal contraction compensation for superconducting and cryo-resistive cables
ES2425540T3 (es) * 2010-02-22 2013-10-16 Medipan Gmbh Procedimiento y dispositivo para la detección simultánea de anticuerpos unidos a sustratos sintéticos y celulares y/o tisulares

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60183559A (ja) * 1984-02-29 1985-09-19 Otsuka Pharmaceut Co Ltd 肝細胞膜抗原に対する自己抗体の測定方法
US5518881A (en) * 1993-11-02 1996-05-21 Flinders Medical Centre Transfected cell lines expressing autoantigens and their use in immunoassays for the detection of autoimmune disease
WO2003016575A1 (en) * 2001-08-17 2003-02-27 Luminex Corporation Method for characterizing autoimmune disorders
WO2003048300A2 (en) * 2001-11-30 2003-06-12 Amnis Corporation Methods of identifying cellular target molecules
WO2010030624A1 (en) * 2008-09-09 2010-03-18 Zeus Scientific, Inc. Methods for diagnosis and assessment of autoimmune disorders

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2012094427A1 *

Also Published As

Publication number Publication date
CA2860690A1 (en) 2012-07-12
EP2661625A1 (de) 2013-11-13
JP2014501932A (ja) 2014-01-23
AU2012204413A1 (en) 2013-08-15
CN103460043A (zh) 2013-12-18
WO2012094427A1 (en) 2012-07-12

Similar Documents

Publication Publication Date Title
DK3505720T3 (en) Cementering under styret tryk
IL230280B (en) Shield unit
EP2705366A4 (de) Diagnosevorrichtung
EP2783627A4 (de) Diagnosevorrichtung
GB201118773D0 (en) Probe
ZA201402224B (en) Diagnostic apparatus
EP2712534A4 (de) Sonde
AP2014007621A0 (en) 2-Thiopyrimidinones
HUP1200607A2 (en) Diagnostic method
GB201008541D0 (en) Diagnostic methods
GB201117538D0 (en) Methods
EP2692275A4 (de) Diagnosesystem
GB201116131D0 (en) Probe
IL227295A0 (en) diagnostic method
GB201016161D0 (en) Diagnostic method
GB201008719D0 (en) Diagnostic method
HK1199475A1 (en) Diagnostic markers
ZA201301498B (en) Diagnostic method
GB201218341D0 (en) Diagnostic method
AP2013007084A0 (en) Diagnostic method
EP2661625A4 (de) Diagnoseverfahren
GB201110712D0 (en) Diagnostic methods
PL2594923T3 (pl) Wstępny system diagnostyczny
ZA201404276B (en) Diagnostic methods
GB201102301D0 (en) Diagnostic methods

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20130801

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20141001

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/50 20060101ALN20140926BHEP

Ipc: G01N 33/564 20060101AFI20140926BHEP

Ipc: G01N 33/53 20060101ALN20140926BHEP

Ipc: G01N 33/543 20060101ALI20140926BHEP

Ipc: G01N 33/68 20060101ALI20140926BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150429